Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Results by year

Table representation of search results timeline featuring number of search results per year.

Year Number of Results
2008 1
2020 1
2022 3
2023 1
2024 0

Text availability

Article attribute

Article type

Publication date

Search Results

6 results

Results by year

Filters applied: . Clear all
Page 1
The rs1883832 Polymorphism (CD40-1C>T) Affects the Intensity of IgA Responses after BNT162b2 Vaccination.
Speletas M, Bakaros E, Peristeri AM, Voulgaridi I, Sarrou S, Paliatsa V, Nasika A, Tseroni M, Anagnostopoulos L, Theodoridou K, Kalala F, Theodoridou A, Mouchtouri BA, Tsiodras S, Eibel H, Hadjichristodoulou C. Speletas M, et al. Among authors: theodoridou a. Int J Mol Sci. 2022 Nov 14;23(22):14056. doi: 10.3390/ijms232214056. Int J Mol Sci. 2022. PMID: 36430533 Free PMC article.
Dynamics of Anti-SARS-CoV-2 IgA and IgG Responses and Their Protective Effect against Fatal Disease after Booster COVID-19 Vaccination.
Speletas M, Voulgaridi I, Bogogiannidou Z, Sarrou S, Kyritsi MA, Theodoridou A, Dadouli K, Matziri A, Vontas A, Pappa D, Konstantinou AK, Tsigalou C, Kalala F, Mouchtouri VA, Hadjichristodoulou C. Speletas M, et al. Among authors: theodoridou a. Vaccines (Basel). 2023 Dec 21;12(1):12. doi: 10.3390/vaccines12010012. Vaccines (Basel). 2023. PMID: 38276671 Free PMC article.
Intensity and Dynamics of Anti-SARS-CoV-2 Immune Responses after BNT162b2 mRNA Vaccination: Implications for Public Health Vaccination Strategies.
Speletas M, Voulgaridi I, Sarrou S, Dadouli A, Mouchtouri VA, Nikoulis DJ, Tsakona M, Kyritsi MA, Peristeri AM, Avakian I, Nasika A, Fragkou PC, Moschopoulos CD, Zoubouneli S, Onoufriadis I, Anagnostopoulos L, Matziri A, Papadamou G, Theodoridou A, Tsiodras S, Hadjichristodoulou C. Speletas M, et al. Among authors: theodoridou a. Vaccines (Basel). 2022 Feb 17;10(2):316. doi: 10.3390/vaccines10020316. Vaccines (Basel). 2022. PMID: 35214774 Free PMC article.
Intensity of Humoral Immune Responses, Adverse Reactions, and Post-Vaccination Morbidity after Adenovirus Vector-Based and mRNA Anti-COVID-19 Vaccines.
Voulgaridi I, Sarrou S, Dadouli A, Peristeri AM, Nasika A, Onoufriadis I, Kyritsi MA, Anagnostopoulos L, Theodoridou A, Avakian I, Pappa D, Konstantinou AK, Papadamou G, Mouchtouri VA, Petinaki E, Speletas M, Hadjichristodoulou C. Voulgaridi I, et al. Among authors: theodoridou a. Vaccines (Basel). 2022 Aug 6;10(8):1268. doi: 10.3390/vaccines10081268. Vaccines (Basel). 2022. PMID: 36016156 Free PMC article.
Evaluation of Two Chemiluminescent and Three ELISA Immunoassays for the Detection of SARS-CoV-2 IgG Antibodies: Implications for Disease Diagnosis and Patients' Management.
Speletas M, Kyritsi MA, Vontas A, Theodoridou A, Chrysanthidis T, Hatzianastasiou S, Petinaki E, Hadjichristodoulou C. Speletas M, et al. Among authors: theodoridou a. Front Immunol. 2020 Dec 23;11:609242. doi: 10.3389/fimmu.2020.609242. eCollection 2020. Front Immunol. 2020. PMID: 33424863 Free PMC article.